| # | Title | Journal | Year | Citations |
|---|
| 1 | Mean Platelet Volume: A Link Between Thrombosis and Inflammation? | Current Pharmaceutical Design | 2011 | 990 |
| 2 | Internet Addiction: A Systematic Review of Epidemiological Research for the Last Decade | Current Pharmaceutical Design | 2014 | 967 |
| 3 | Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities | Current Pharmaceutical Design | 2004 | 808 |
| 4 | The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease | Current Pharmaceutical Design | 2009 | 775 |
| 5 | Uric Acid and Oxidative Stress | Current Pharmaceutical Design | 2005 | 767 |
| 6 | Bioactive Proteins and Peptides from Food Sources. Applications of Bioprocesses used in Isolation and Recovery | Current Pharmaceutical Design | 2003 | 745 |
| 7 | Food-derived Bioactive Peptides - Opportunities for Designing Future Foods | Current Pharmaceutical Design | 2003 | 679 |
| 8 | Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases | Current Pharmaceutical Design | 2013 | 566 |
| 9 | Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease | Current Pharmaceutical Design | 2010 | 547 |
| 10 | New Insights Into the Molecular Mechanisms of Action of Bisphosphonates | Current Pharmaceutical Design | 2003 | 517 |
| 11 | Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer | Current Pharmaceutical Design | 2004 | 517 |
| 12 | Oxygen, Reactive Oxygen Species and Tissue Damage | Current Pharmaceutical Design | 2004 | 517 |
| 13 | Polymeric Micelles for Drug Delivery | Current Pharmaceutical Design | 2006 | 508 |
| 14 | The Roles of Antimicrobial Peptides in Innate Host Defense | Current Pharmaceutical Design | 2009 | 498 |
| 15 | ABC Transporters and the Blood-Brain Barrier | Current Pharmaceutical Design | 2004 | 490 |
| 16 | Recent Developments in the Field of Tumor-Inhibiting Metal Complexes | Current Pharmaceutical Design | 2003 | 484 |
| 17 | Carbonic Anhydrases An Overview | Current Pharmaceutical Design | 2008 | 476 |
| 18 | Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology | Current Pharmaceutical Design | 2005 | 460 |
| 19 | Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization | Current Pharmaceutical Design | 2010 | 455 |
| 20 | Social Network Site Addiction - An Overview | Current Pharmaceutical Design | 2014 | 452 |
| 21 | Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects | Current Pharmaceutical Design | 2010 | 451 |
| 22 | Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils | Current Pharmaceutical Design | 2008 | 442 |
| 23 | ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development | Current Pharmaceutical Design | 2014 | 441 |
| 24 | Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity | Current Pharmaceutical Design | 2008 | 434 |
| 25 | Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy | Current Pharmaceutical Design | 2005 | 432 |
| 26 | Novel Metals and Metal Complexes as Platforms for Cancer Therapy | Current Pharmaceutical Design | 2010 | 427 |
| 27 | Recent Developments of the Chemistry Development Kit (CDK) - An Open-Source Java Library for Chemo- and Bioinformatics | Current Pharmaceutical Design | 2006 | 418 |
| 28 | Propofol: Therapeutic Indications and Side-Effects | Current Pharmaceutical Design | 2004 | 403 |
| 29 | Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets | Current Pharmaceutical Design | 2007 | 398 |
| 30 | Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production | Current Pharmaceutical Design | 2007 | 397 |
| 31 | The Role of Cytokines in Sleep Regulation | Current Pharmaceutical Design | 2008 | 386 |
| 32 | An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging | Current Pharmaceutical Design | 2009 | 386 |
| 33 | Intercalators as Anticancer Drugs | Current Pharmaceutical Design | 2001 | 384 |
| 34 | Why Drugs Fail - A Study on Side Effects in New Chemical Entities | Current Pharmaceutical Design | 2005 | 383 |
| 35 | Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence | Current Pharmaceutical Design | 2013 | 377 |
| 36 | Current Developments of Coumarin Compounds in Medicinal Chemistry | Current Pharmaceutical Design | 2013 | 374 |
| 37 | Inflammatory Process in Parkinsons Disease: Role for Cytokines | Current Pharmaceutical Design | 2005 | 370 |
| 38 | Predictive QSAR Modeling Workflow, Model Applicability Domains, and Virtual Screening | Current Pharmaceutical Design | 2007 | 369 |
| 39 | The Urokinase Plasminogen Activator System: Role in Malignancy | Current Pharmaceutical Design | 2004 | 356 |
| 40 | Aminoglycoside-Induced Ototoxicity | Current Pharmaceutical Design | 2007 | 356 |
| 41 | Lactoferrin as a Natural Immune Modulator | Current Pharmaceutical Design | 2009 | 354 |
| 42 | Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials | Current Pharmaceutical Design | 2012 | 349 |
| 43 | Biofunctional Peptides from Milk Proteins: Mineral Binding and Cytomodulatory Effects | Current Pharmaceutical Design | 2003 | 347 |
| 44 | Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns? | Current Pharmaceutical Design | 2004 | 344 |
| 45 | Molecular Link Mechanisms between Inflammation and Cancer | Current Pharmaceutical Design | 2012 | 344 |
| 46 | Pollution, Toxicity and Carcinogenicity of Organic Dyes and their Catalytic Bio-Remediation | Current Pharmaceutical Design | 2019 | 336 |
| 47 | The Antioxidants and Pro-Antioxidants Network: An Overview | Current Pharmaceutical Design | 2004 | 331 |
| 48 | Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today | Current Pharmaceutical Design | 2009 | 331 |
| 49 | Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis | Current Pharmaceutical Design | 2012 | 331 |
| 50 | Oxidative Stress and Cancer | Current Pharmaceutical Design | 2019 | 331 |
